The bill would make it harder to obtain the pills by placing it on the list of Schedule IV drugs under the state's Uniform Controlled Dangerous Substances Law.
The bill would make it harder to obtain the pills by placing it on the list of Schedule IV drugs under the state's Uniform Controlled Dangerous Substances Law.
The bill would make it harder to obtain the pills by placing it on the list of Schedule IV drugs under the state's Uniform Controlled Dangerous Substances Law.
The bill would make it harder to obtain the pills by placing it on the list of Schedule IV drugs under the state's Uniform Controlled Dangerous Substances Law.
The bill would make it harder to obtain the pills by placing it on the list of Schedule IV drugs under the state's Uniform Controlled Dangerous Substances Law.
The bill would make it harder to obtain the pills by placing it on the list of Schedule IV drugs under the state's Uniform Controlled Dangerous Substances Law.
(MedPage Today) -- Two abortion-inducing drugs could soon be reclassified as controlled and dangerous substances in Louisiana under a first-of-its-kind bill that received final legislative passage Thursday and is expected to be signed into…
Two abortion-inducing drugs could soon be reclassified as controlled and dangerous substances in Louisiana under a first-of-its-kind bill that received final legislative passage Thursday and is expected to be signed into law by the…
The Louisiana Senate on Thursday passed a bill that classifies two drugs used in medication abortions as controlled substances, creating a new hurdle for the most common method of abortion in the United States.
Louisiana lawmakers passed legislation Thursday to make the state the first in the nation to designate abortion pills as dangerous controlled substances. Possession of the drugs without a prescription would be a crime punishable with jail…
Republican lawmakers in the southern US state of Louisiana gave final approval Thursday to a bill that would criminalise possession of abortion pills without a prescription.
Researchers show in animal models that a novel, non-hormonal sperm-specific approach offers a promising option for reversible human male contraception.